Annexin A2 Reduces PCSK9 Protein Levels via a Translational Mechanism and Interacts with the M1 and M2 Domains of PCSK9

Annexin A2 (AnxA2) was reported to be an extracellular endogenous inhibitor of proprotein convertase subtilisin kexin type 9 (PCSK9) activity on cell-surface LDL receptor degradation. In this study, we investigated the effect of silencing the expression of AnxA2 and PCSK9 in HepG2 and Huh7 cells to...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Ly, Kévin, Luna Saavedra, Yascara Grisel, Canuel, Maryssa, Routhier, Sophie, Desjardins, Roxane, Hamelin, Josée, Mayne, Janice, Lazure, Claude, Seidah, Nabil G., Day, Robert
Format: Artigo
Idioma:Inglês
Publicat: American Society for Biochemistry and Molecular Biology 2014
Matèries:
Cell Biology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4067207/
https://ncbi.nlm.nih.gov/pubmed/24808179
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1074/jbc.M113.541094
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars